Kworweinski Lafontant, David H Fukuda, Estefania Zamarripa, Abigail L Tice, Jethro Raphael M Suarez, Chitra Banarjee, Dahee Kim, Jeffrey R Stout, Joon-Hyuk Park, Rui Xie, Ladda Thiamwong
{"title":"Application of Levi's Muscle Index in frailty assessment: comparison of bioimpedance measures among older adults.","authors":"Kworweinski Lafontant, David H Fukuda, Estefania Zamarripa, Abigail L Tice, Jethro Raphael M Suarez, Chitra Banarjee, Dahee Kim, Jeffrey R Stout, Joon-Hyuk Park, Rui Xie, Ladda Thiamwong","doi":"10.3389/fmed.2025.1525569","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Frailty is prevalent among older adults and is characterized by reductions in physical function and muscle quality. Despite the emerging clinical utility of bioelectrical impedance analysis (BIA) and phase angle (PhA) as a bioimpedance index, little is known about how bioimpedance indices such as Levi's Muscle Index (LMI), reactance/height (Xc/Height), and resistance/height (R/Height), relate to physical function and frailty.</p><p><strong>Methods: </strong>This cross-sectional study examined 208 community-dwelling older adults (female, <i>n</i> = 183; age = 74.2 ± 6.9 years; BMI = 30.4 ± 6.4 kg/m<sup>2</sup>) to compare physical function measures and bioimpedance indices across frailty categories determined by the FRAIL questionnaire. PhA, LMI, Xc/Height, and R/Height were all assessed at 50 kHz using a direct segmental multi-frequency InBody s10 BIA device. Physical function was assessed using handgrip strength, postural sway, Timed-Up-and-Go, and the Short Physical Performance Battery. Data were analyzed using Spearman rho (ρ) and Pearson r correlation coefficients, and group differences were examined using Kruskal-Wallis H tests and one-way ANOVA.</p><p><strong>Results: </strong>PhA (<i>r</i> = -0.18, <i>p</i> = 0.01) and Xc/Height (<i>r</i> = -0.24, <i>p</i> < 0.001) were significantly associated with FRAIL scores. LMI and PhA were well correlated with each other (ρ = 0.76, <i>p</i> < 0.001), yet Xc/Height was the only bioimpedance index to significantly differ between frailty categories (<i>F</i> = 6.39, <i>p</i> = 0.002, ηp<sup>2</sup> = 0.06).</p><p><strong>Conclusion: </strong>Results suggest Xc/Height may be the only bioimpedance index indicative of frailty among older adults. Given the variety of assessments used to categorize frailty, these conclusions may be limited to the use of the FRAIL questionnaire; future research should compare LMI and PhA using multiple frailty indices.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1525569"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12243873/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1525569","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Frailty is prevalent among older adults and is characterized by reductions in physical function and muscle quality. Despite the emerging clinical utility of bioelectrical impedance analysis (BIA) and phase angle (PhA) as a bioimpedance index, little is known about how bioimpedance indices such as Levi's Muscle Index (LMI), reactance/height (Xc/Height), and resistance/height (R/Height), relate to physical function and frailty.
Methods: This cross-sectional study examined 208 community-dwelling older adults (female, n = 183; age = 74.2 ± 6.9 years; BMI = 30.4 ± 6.4 kg/m2) to compare physical function measures and bioimpedance indices across frailty categories determined by the FRAIL questionnaire. PhA, LMI, Xc/Height, and R/Height were all assessed at 50 kHz using a direct segmental multi-frequency InBody s10 BIA device. Physical function was assessed using handgrip strength, postural sway, Timed-Up-and-Go, and the Short Physical Performance Battery. Data were analyzed using Spearman rho (ρ) and Pearson r correlation coefficients, and group differences were examined using Kruskal-Wallis H tests and one-way ANOVA.
Results: PhA (r = -0.18, p = 0.01) and Xc/Height (r = -0.24, p < 0.001) were significantly associated with FRAIL scores. LMI and PhA were well correlated with each other (ρ = 0.76, p < 0.001), yet Xc/Height was the only bioimpedance index to significantly differ between frailty categories (F = 6.39, p = 0.002, ηp2 = 0.06).
Conclusion: Results suggest Xc/Height may be the only bioimpedance index indicative of frailty among older adults. Given the variety of assessments used to categorize frailty, these conclusions may be limited to the use of the FRAIL questionnaire; future research should compare LMI and PhA using multiple frailty indices.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world